What Is Synthetic Biology and Why Does It Matter for Plastics?

Synthetic biology is an interdisciplinary field that applies engineering principles to biology. It involves redesigning organisms for useful purposes by engineering them to have new abilities. Researchers can write new genetic code—much like writing software—to make microbes produce chemicals, fuels, and materials that were once derived from fossil resources. In the context of plastics, synthetic biology makes it possible to program microorganisms to synthesize polymers directly from renewable feedstocks such as corn sugar, sugarcane, or even captured carbon dioxide.

The core toolkit includes DNA synthesis, gene editing (especially CRISPR-Cas9), and metabolic pathway engineering. By assembling novel combinations of genes, scientists can create cellular factories that churn out high-value compounds with precision. This opens the door to producing bio-based plastics that are both functionally competitive with petrochemical plastics and genuinely sustainable.

For example, a 2021 study in Nature Biotechnology demonstrated engineered E. coli that produced polyhydroxyalkanoates (PHAs) at yields suitable for commercial scale. Such breakthroughs are accelerating the timeline for bio-based plastics to reach the market.

Synthetic Biology Techniques Driving Bio-Based Plastic Development

Metabolic Pathway Engineering

Metabolic engineering is the foundation. Scientists design new pathways in organisms like E. coli, yeast, or cyanobacteria to convert simple sugars into polymer precursors. For polyhydroxyalkanoates (PHAs), the pathway involves enzymes that polymerize hydroxyacyl-CoA monomers inside the cell. By fine-tuning enzyme expression and blocking competing pathways, researchers can push carbon flux toward polymer accumulation, sometimes achieving over 80% of the cell’s dry weight as PHA.

A similar approach is used for polylactic acid (PLA), though PLA is typically produced via fermentation of lactic acid followed by chemical polymerization. Synthetic biology now enables direct biological production of lactide, the cyclic dimer of lactic acid, which can be polymerized without separate chemical steps. Genomatica, a leader in industrial biotechnology, has pioneered such routes for bio-based monomers used in nylon and polyester replacements.

CRISPR and Genome Editing

CRISPR-Cas9 has dramatically shortened the design-build-test-learn cycle. Where traditional genetic engineering took months to modify a single gene, CRISPR can make multiple edits in a week. This allows rapid prototyping of synthetic pathways. For instance, teams at the University of California have used CRISPR to engineer Pseudomonas putida to produce medium-chain-length PHAs with tailored mechanical properties—from flexible films to rigid thermoplastics.

Cell-Free Systems

An emerging approach is cell-free synthetic biology, where enzyme cocktails are assembled in vitro to produce polymers outside living cells. This avoids issues of toxicity and metabolic burden. Startups like EnginZyme are developing cell-free platforms for scalable bioplastic production that can operate continuously, cutting costs and energy use.

Key Bio-Based Plastics Enabled by Synthetic Biology

Polyhydroxyalkanoates (PHA)

PHAs are polyesters produced by bacteria as energy storage. They are fully biodegradable in marine and soil environments. Synthetic biology has enabled production in heterologous hosts like yeast, which are easier to cultivate and harvest. Companies such as Danimer Scientific and CJ CheilJedang are commercializing PHA for packaging, straws, and coatings. Danimer Scientific’s Nodax® PHA is certified biodegradable and used by major brands.

Polylactic Acid (PLA) via Biomass Fermentation

PLA is currently the most common bio-based plastic, made from fermented plant sugars. Synthetic biology has improved the efficiency of lactic acid production in microorganisms, reducing cost and energy. Recent advances allow production of high-optical-purity L-lactic acid, which yields stronger PLA. Metabolic engineers at TotalEnergies Corbion have achieved yields of 95% or better in optimized yeast strains.

Bio-Based Polyethylene and Polyesters

Traditional polyethylene can be made from bio-ethanol (ethanol from corn or sugarcane) via dehydration to ethylene. Synthetic biology is now used to engineer microbes that produce ethylene directly from sugars, bypassing the ethanol step. Similarly, bio-based polyethylene terephthalate (bio-PET) is moving forward with engineered organisms that produce terephthalic acid from biomass. LanzaTech uses gas fermentation to convert industrial carbon emissions into ethylene glycol, a PET precursor.

Advantages of Synthetic Biology–Driven Bio-Plastics

  • Renewable feedstocks: Uses agricultural waste, sugarcane, or captured CO2 instead of fossil oil.
  • Lower carbon footprint: Life-cycle assessments show up to 80% reduction in greenhouse gas emissions compared to conventional plastics.
  • Biodegradability: Many bio-based plastics like PHA are compostable in industrial facilities and even home environments.
  • Customizable properties: By adjusting monomer composition, synthetic biology can produce plastics that are rigid, flexible, or stretchable—tailored for specific applications.
  • Faster iteration: DNA synthesis and high-throughput screening accelerate discovery of new polymer variants.

For example, a team from MIT used directed evolution to create a novel PHA copolymer that is both strong and elastic, opening uses in medical sutures and biodegradable packaging films.

Case Study: Industrial-Scale PHA Production

One of the most advanced synthetic biology projects for bio-plastics is the production of PHA by companies like Newlight Technologies. Their process uses methane-consuming bacteria combined with synthetic gene circuits to convert methane (a potent greenhouse gas) into PHA polymers. The result is a carbon-negative plastic. In partnership with IKEA, Newlight is developing biodegradable home products. Another example is Mango Materials, which uses engineered methanotrophs to produce PHA from waste biogas.

These projects demonstrate the scalability potential when synthetic biology is combined with industrial fermentation. Pilot plants are now in operation, and the first commercial products are reaching shelves.

Challenges and Solutions

Cost Competitiveness

Bio-based plastics currently cost 2–3 times more than petroleum-based counterparts. Synthetic biology addresses this by improving yield, titer, and productivity. For instance, engineering strains to tolerate high product concentrations reduces downstream processing costs. Metabolic fluxes can be optimized using machine learning models that predict enzyme bottlenecks.

Feedstock Sustainability

Relying on food crops (corn, sugarcane) raises land-use concerns. Synthetic biology enables use of lignocellulosic biomass (agricultural residues like corn stover or wood chips) by engineering microbes that break down cellulose and hemicellulose. Advanced strains of Yarrowia lipolytica have been engineered to co-utilize xylose and glucose from biomass hydrolysates, achieving high PHA yields without competing with food supply.

End-of-Life Management

Not all bio-based plastics are biodegradable. Synthetic biology can incorporate enzymatic breakdown tags into the polymer backbone, enabling triggered degradation. Companies like Carbios use engineered enzymes to depolymerize PET and PLA into monomers for recycling. Carbios’ enzymatic recycling process works on conventional PET as well, linking synthetic biology to a circular plastic economy.

Future Outlook: Toward a Circular Bioeconomy

Synthetic biology is set to transform the plastic industry from linear (take-make-waste) to circular. Future developments include:

  • Designer microbes that produce “self-healing” plastics that can repair cracks using embedded synthetic circuits.
  • Living materials where bacteria remain in the final product, providing biodegradability on demand.
  • Artificial intelligence–guided design of new polymers with properties equal or superior to petrochemical plastics, such as barrier properties for food packaging.
  • Integration with carbon capture technologies: feedstocks from captured CO2 converted into bio-plastics via engineered cyanobacteria or chemolithoautotrophs.

Policy support is also growing. The European Union’s Green Deal and the U.S. Bioeconomy Initiative fund research into bio-based alternatives. Consumer demand for sustainable packaging is driving retailer commitments: by 2030, many major brands aim to make all packaging recyclable, reusable, or compostable. Synthetic biology is the engine that can deliver those materials at scale.

Conclusion

Synthetic biology is not merely an incremental improvement—it is a paradigm shift in how we produce plastics. By reprogramming microorganisms to build polymers from renewable carbon, we can create materials that are high-performing, biodegradable, and carbon neutral or even negative. The technology has moved from lab curiosity to real-world commercial production. As costs continue to drop and new feedstocks become viable, bio-based plastics powered by synthetic biology will become a standard part of the global materials supply chain, helping to decouple plastic production from fossil resources and mitigate the environmental crisis of plastic pollution.